In general, I would like to know if pharmaceutical companies typically update their DMF documents with the FDA with annual revalidation data for critical manufacturing equipment or is it sufficient to describe the revalidation process and frequency in the body of the document without adding the data from the executed revalidation?
------------------------------
Gwendolyn Lohr
Regulatory & Compliance Specialist
United States
------------------------------